Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03077620 · ClinicalTrials.gov registry record · NA
Sleep Quality and Amyloid-Beta Kinetics
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT03077620 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 48 participants.
The verdict
NCT03077620, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to change the concentration of amyloid-beta in human cerebrospinal fluid (CSF) by modification of sleep efficiency.
Interventions
- DRUG Placebo
- DRUG Suvorexant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2016-11 |
| Est. Completion | 2021-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03077620
The ClinicalTrials.gov registry entry for NCT03077620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03077620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03077620 about?
NCT03077620 is a clinical study titled "Sleep Quality and Amyloid-Beta Kinetics". The purpose of this study is to change the concentration of amyloid-beta in human cerebrospinal fluid (CSF) by modification of sleep efficiency.
What is the current status of trial NCT03077620?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2016-11. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT03077620?
The interventions under investigation include: Placebo (DRUG), Suvorexant (DRUG).
Who is sponsoring clinical trial NCT03077620?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.